b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31466595</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>11</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>11</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1558-0520</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>37</Volume>\n                    <Issue>4</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Oct</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Dermatologic clinics</Title>\n                <ISOAbbreviation>Dermatol Clin</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Cutaneous Adverse Reactions of Anticancer Agents.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>555-568</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0733-8635(19)30055-5</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.det.2019.05.013</ELocationID>\n            <Abstract>\n                <AbstractText>Cutaneous adverse effects are one of the most frequently observed adverse reactions with anticancer agents. This has only intensified with newer targeted and immunologic agents that present with a wide array of drug toxicities and skin reactions. The spectrum ranges from benign, localized dermatoses to generalized, life-threatening cutaneous toxicities. Herein, the authors review the cutaneous adverse effects observed with conventional chemotherapy as well as targeted agents, including the emerging immune checkpoint inhibitors, which have been revolutionary in the treatment of many malignancies.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 Elsevier Inc. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Kaul</LastName>\n                    <ForeName>Subuhi</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kaffenberger</LastName>\n                    <ForeName>Benjamin H</ForeName>\n                    <Initials>BH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Ohio State Dermatology, 1328 Dublin Road, Suite 100, Columbus, OH 43212, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Choi</LastName>\n                    <ForeName>Jennifer N</ForeName>\n                    <Initials>JN</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, Division of Oncodermatology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, 676 North Street Clair, Suite 1600, Chicago, IL 60611, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kwatra</LastName>\n                    <ForeName>Shawn G</ForeName>\n                    <Initials>SG</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Johns Hopkins University School of Medicine, 1550 Orleans Street, CRB II Suite 206, Baltimore, MD 21231, USA. Electronic address: skwatra1@jhmi.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016454">Review</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>27</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Dermatol Clin</MedlineTA>\n            <NlmUniqueID>8300886</NlmUniqueID>\n            <ISSNLinking>0733-8635</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003875" MajorTopicYN="N">Drug Eruptions</DescriptorName>\n                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>\n                <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012871" MajorTopicYN="N">Skin Diseases</DescriptorName>\n                <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>\n                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Anticancer</Keyword>\n            <Keyword MajorTopicYN="N">Chemotherapy</Keyword>\n            <Keyword MajorTopicYN="N">Cutaneous adverse effects</Keyword>\n            <Keyword MajorTopicYN="N">Drugs</Keyword>\n            <Keyword MajorTopicYN="N">Immunotherapy</Keyword>\n            <Keyword MajorTopicYN="N">Skin</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>2</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31466595</ArticleId>\n            <ArticleId IdType="pii">S0733-8635(19)30055-5</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.det.2019.05.013</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'